Osteoblastic bone formation is induced by using nanogel-crosslinking hydrogel as novel scaffold for bone growth factor

Journal of Cellular Physiology

Volumn 220, Issue 1, 2009, Pages 1-7

  Hayashi, Chikako ^a   Hasegawa, Urara ^a   Saita, Yoshitomo ^a   Hemmi, Hiroaki ^a   Hayata, Tadayoshi ^a   Nakashima, Kazuhisa ^a   Ezura, Yoichi ^a   Amagasa, Teruo ^a   Akiyoshi, Kazunari ^a   Noda, Masaki ^a,b  

^a Tokyo Medical and Dental University ^*  (Japan)

^b JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CHOLESTEROL BEARING PULLULAN; NANOPARTICLE; PULLULAN; TISSUE SCAFFOLD; UNCLASSIFIED DRUG; BMP2 PROTEIN, HUMAN; CHOLESTEROL; CROSS LINKING REAGENT; DRUG CARRIER; GLUCAN; MACROGOL DERIVATIVE; NANOGEL; POLYETHYLENEIMINE; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEFECT; BONE DEVELOPMENT; CELL ACTIVATION; CELL CULTURE; CONTROLLED STUDY; CROSS LINKING; FRACTURE HEALING; HISTOPATHOLOGY; HYDROGEL; MALE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN SECRETION; ANIMAL; BONE REGENERATION; CHEMISTRY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; DRUG IMPLANT; HETEROTOPIC OSSIFICATION; HUMAN; INSTITUTE FOR CANCER RESEARCH MOUSE; KINETICS; MICRO-COMPUTED TOMOGRAPHY; PATHOLOGY; PATHOPHYSIOLOGY; SKULL; SOLUBILITY; TISSUE ENGINEERING;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; CHOLESTEROL; CROSS-LINKING REAGENTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; DRUG IMPLANTS; GLUCANS; HUMANS; HYDROGELS; KINETICS; MALE; MICE; MICE, INBRED ICR; OSSIFICATION, HETEROTOPIC; OSTEOBLASTS; OSTEOGENESIS; POLYETHYLENE GLYCOLS; POLYETHYLENEIMINE; RECOMBINANT PROTEINS; SKULL; SOLUBILITY; TISSUE ENGINEERING; TISSUE SCAFFOLDS; X-RAY MICROTOMOGRAPHY;

EID: 65549157815     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21760     Document Type: Article

References (31)

1. Akiyoshi K, Deguchi S, Moriguchi N, Yamaguchi S, Sunamoto J. 1993. Self-aggregates of hydrophobized polysaccharides in water - formation and characteristics of nanoparticles. Macromolecules 26:3062-3068.
2. Akiyoshi K, Taniguchi I, Fukui H, Sunamoto J. 1996. Hybrid nanoparticle formed by self-assembly of hydrophobized polysaccharide. Stabilization of adriamycin by complexation. Eur J Pharm Biopharm 42:286-290.
3. Akiyoshi K, Deguchi S, Tajima T, Nishikawa T, Sunamoto J. 1997. Microscopic structure and thermoresponsiveness of a hydrogel nanoparticle by self-assembly of a hydrophobized polysaccharide. Macromolecules 30:857-861.
4. Akiyoshi K, Kobayashi S, Shichibe S, Mix D, Baudys M, Kim SW, Sunamoto J. 1998. Self-assembled hydrogel nanoparticle of cholesterol-bearing pullulan as a carrier of protein drugs: Complexation and stabilization of insulin. J Control Release 54:313-320.
5. Giannoudis PV, Tzioupis C. 2005. Clinical applications of BMP-7: The UK perspective. Injury 36:S47-S50.
6. Hirakura T, Nomura Y, Aoyama Y, Akiyoshi K. 2004. Photoresponsive nanogels formed by the self-assembly of spiropyrane-bearing pullulan that act as artificial molecular chaperones. Biomacromolecules 5:1804-1809.
7. Ikuta Y, Katayama N, Wang L, Okugawa T, Takahashi Y, Schmitt M, Gu X, Watanabe M, Akiyoshi K, Nakamura H, Kuribayashi K, Sunamoto J, Shiku H. 2002. Presentation of a major histocompatibility complex class 1-binding peptide by polysaccharide-truncated HER2 protein complex: Implications for polyvalent immuno-cell therapy. Blood 99:3717-3724.
8. Ishijima M, Rittling SR, Yamashita T, Tsuji K, Kurosawa H, Nifuji A, Denhardt DT, Noda M. 2001. Enhancement of osteoclastic bone resorption and suppression of osteoblastic bone formation in response to reduced mechanical stress do not occur in the absence of osteopontin. J Exp Med 193:399-404.
9. Kageyama S, Kitano S, Hirayama M, Nagata Y, Imai H, Shiraishi T, Akiyoshi K, Scott A, Murphy R, Hoffman E, Old L, Katayama N, Shiku H. 2008. Humoral immune responses in patients vaccinated with 1-146 HER2 protein complexed with cholesteryl pullulan nanogel (CHP-HER2). Cancer Sci 99:601-607.
10. 2 effects on bone formation. J Cell Biochem 101:1063-1070.
11. Lutolf MP, Hubbell JA. 2005. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 23:47-55.
12. Lutolf MP, Weber FE, Schmoekel HG, Schense JC, Kohler T, Muller R, Hubbell JA. 2003. Repair of bone defects using synthetic mimetics of collagenous extracellular matrices. Nat Biotechnol 21:513-518.
13. Maeda Y, Tsuji K, Nifuji A, Noda M. 2004. Inhibitory helix-loop-helix transcription f actors Id1/Id3 promote bone formation in vivo. J Cell Biochem 93:337-344.
14. Morimoto N, Endo T, Iwasaki Y, Akiyoshi K. 2005. Design of hybrid hydrogels with self-assembled nanogels as cross-linkers: Interaction with proteins and chaperone-like activity. Biomacromolecules 6:1829-1834.
15. Morinobu M, Nakamoto T, Hino K, Tsuji K, Shen ZJ, Nakashima K, Nifuji A, Yamamoto H, Hirai H, Noda M. 2005. The nucleocytoplasmic shuttling protein CIZ reduces adult bone mass by inhibiting bone morphogenetic protein-induced bone formation. J Exp Med 201:961-970.
16. Nishikawa T, Akiyoshi K, Sunamoto J. 1994. Supramolecular assembly between nanoparticles of hydrophobized polysaccharide and soluble protein complexation between the self-aggregate of cholesterol-bearing pullulan and .alpha.-chymotrypsin. Macromolecules 27:7654-7659.
17. Nishikawa T, Akiyoshi K, Sunamoto J. 1996. Macromolecular complexation between bovine serum albumin and the self-assembled hydrogel nanoparticle of hydrophobized polysaccharides. J Am Chem Soc 118:6110-6115.
18. Noda M, Camilliere JJ. 1989. In vivo stimulation of bone formation by transforming growth factor-beta. Endocrinology 124:2991-2994.
19. Noda M, Rodan GA. 1989. Transcriptional regulation of osteopontin production in rat osteoblast-like cells by parathyroid hormone. J Cell Biol 108:713-718.
20. Noda M, Yoon K, Rodan GA, Koppel DE. 1987. High lateral mobility of endogenous and transfected alkaline phosphatase: A phosphatidylinositol-anchored membrane protein. J Cell Biol 105:1671-1677.
21. Noda M, Yoon K, Prince CW, Butler WT, Rodan GA. 1988. Transcriptional regulation of osteopontin production in rat osteosarcoma cells by type beta transforming growth factor. J Biol Chem 263:13916-13921.
22. Noda M, Vogel RL, Craig AM, Prahl J, DeLuca HF, Denhardt DT. 1990. Identification of a DNA sequence responsible for binding of the 1,25-dihydroxyvitamin D3 receptor and 1,25-dihydroxyvitamin D3 enhancement of mouse secreted phosphoprotein 1 (SPP-1 or osteopontin) gene expression. Proc Natl Acad Sci USA 87:9995-9999.
23. Nomura Y, Ikeda M, Yamaguchi N, Aoyama Y, Akiyoshi K. 2003. Protein refolding assisted by self-assembled nanogels as novel artificial molecular chaperone. FEBS Lett 553:271-276.
24. Nomura Y, Sasaki Y, Takagi M, Narita T, Aoyama Y, Akiyoshi K. 2005. Thermoresposive controlled association of protein with a dynamic nanogel of hydrophobized polysaccharide and cyclodextrin: Heat shock protein-like activity of artificial molecular chaperone. Biomacromolecules 6:447-452.
25. Peppas NA, Hilt JZ, Khademhosseini A, Langer R. 2006. Hydrogels in biology and medicine: From molecular principles to bionanotechnology. Adv Mater 18:1345-1360.
26. Saito N, Okada T, Horiuchi H, Murakami N, Takahashi J, Nawata M, Ota H, Nozaki K, Takaoka K. 2001. A biodegradable polymer as a cytokine delivery system for inducing bone formation. Nat Biotechnol 19:332-335.
27. Tabata Y. 2005. Significance of release technology in tissue engineering. Drug Discov Today 10:1639-1646.
28. Taniguchi I, Akiyoshi K, Sunamoto J. 1999. Cell specificity of macromolecular assembly of cholesteryl and galactoside groups-conjugated pullulan. J Bioact Compat Polym 14:195-212.
29. Yamamoto M, Takahashi Y, Tabata Y. 2003. Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein. Biomaterials 24:4375-4383.
30. Yoshida Y, Tanaka S, Umemori H, Minowa O, Usui M, Ikematsu N, Hosoda E, Imamura T, Kuno J, Yamashita T, Miyazono K, Noda M, Noda T, Yamamoto T. 2000. Negative regulation of BMP/Smad signaling by Tob in osteoblasts. Cell 103:1085-1097.
31. Yoshitake H, Rittling SR, Denhardt DT, Noda M. 1999. Osteopontin- deficient mice are resistant to ovariectomy-induced bone resorption. Proc Natl Acad Sci USA 96:8156-8160.